708
Views
43
CrossRef citations to date
0
Altmetric
Articles

Severity of Kratom (Mitragyna speciosa Korth.) Psychological Withdrawal Symptoms

, Ph.D., , Ph.D., , Ph.D., , M.D., , M.S., , M.D. ORCID Icon & , Ph.D. show all
Pages 445-450 | Received 27 Mar 2018, Accepted 18 Jun 2018, Published online: 28 Aug 2018
 

ABSTRACT

Kratom leaves (Mitragyna speciosa Korth.) are traditionally used in Southeast Asia for their medicinal value. Self-report studies suggest that cessation from chronic kratom tea consumption (freshly brewed kratom tea) was associated with unpleasant psychological symptoms. This study sought to assess the severity of anxiety and depression during kratom cessation. Regular kratom users (N = 150) were recruited from the northern state of Penang (Malaysia) for this retrospective study. The Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) scales were used to assess the severity of the symptoms of anxiety and depression. Most respondents (70%) experienced symptoms of mild anxiety, while 81% experienced symptoms of mild depression during kratom cessation. Those who consumed higher quantities of kratom tea daily (≥4 glasses) had higher odds of reporting longer duration of kratom use history (OR = 4.8, 95% CI 2.3 −10.1, < 0.001), higher frequency of daily kratom use (≥4 times) (OR = 72, CI 9.5– 543.1, < 0.001), and were more likely to experience moderate symptoms of depression (OR = 2.9, CI 1.1–7.3, = 0.020) during kratom cessation than those who consumed between one and three glasses of kratom tea per day. Cessation from regular and long-term kratom tea consumption was not associated with symptoms of high anxiety or depression.

Acknowledgments

We thank Muhammad Eshal Bin Dzulkapli for his assistance in the data collection process.

Additional information

Funding

We thank Universiti Sains Malaysia for the Research University grant (1001/CDADAH/816306).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.